A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
Study sponsor: Ascentage Pharma Group Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2024-08-01Actual
Enrollment · participants144Actual
Source updated2025-03-03Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.